We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more
For more information, go to

Our history and achievements

The early years

Arthritis Research UK began life as the Empire Rheumatism Council, set up in 1936 by Dr Will Copeman, an eminent physician and Fellow of the Royal College of Physicians (RCP), and other like-minded doctors, who were committed to stopping the pain of arthritis.

In the 1950s, the charity began to train doctors and medical students and educate the public. The first information booklet, on rheumatoid arthritis, was published in 1956; osteoarthritis followed two years later.

From the 1960s onwards our research began to show that arthritis is neither simply a wear and tear condition, nor an inevitable part of ageing.

Arthritis Research UK’s flagship research centre, the Kennedy Institute, was responsible for the charity’s biggest success yet. Scientists Tiny Maini and Marc Feldmann research into the activities of a disease-causing molecule called tumour necrosis factor (TNF) in the 1990s. This led to a whole new class of drugs called anti-TNF therapy, transforming the lives of people with rheumatoid and other types of inflammatory arthritis over the past 20 years.

Recent years

In more recent years we have undertaken big genome screens to find the genes that cause osteoarthritis, lupus and ankylosing spondylitis.  We have invested in research to help the millions of people living with osteoarthritis, previously a hugely underfunded area of research, despite causing pain and disability to eight million people in the UK.

Our network of experimental treatment centres have supported the testing and development of new treatment for arthritis and related conditions.

Another exciting development is the use of targeted treatments. Instead of treating all patients with a particular type of arthritis in the same way, the treatment they receive is personalised based on the way the patient experiences their condition and how this affects their response to treatment. This could help the thousands of people with rheumatoid arthritis for whom current drug therapies don’t work.

We've worked also hard to ensure key decision makers in government at all levels take arthritis more seriously, and make it a priority. Our reports have helped to improve government policy relating to people with arthritis in the healthcare and public health systems.

Learn more about our work:

Allison’s story – rheumatoid arthritis and anti-TNF

Allison Morsali

Read how anti-TNF therapy helped Allison beat the pain from her rheumatoid arthritis.

For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.